Peptidase Inhibition and AnalysisHepatocellular Carcinoma Treatment and PrognosisCell Adhesion Molecules Research
DOI: 10.1615/critreveukaryotgeneexpr.2026063933

Abstract

Abstract is not available.

Citation format

LI, Yumin. CD58: A promising diagnostic and prognostic biomarker for hepatocellular carcinoma. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2026.